Abstract:Novel genetically engineered mouse models using the Cre-loxP or the Flp-FRT systems have generated useful reagents to manipulate the mouse genome in a temporally-regulated and tissue-specific manner. By incorporating a constitutive Cre driver line into a mouse model in which FRT-regulated genes in other cell types are regulated by Flp-FRT recombinase, gene expression can be manipulated simultaneously in separate tissue compartments. This application of dual recombinase technology can be used to dissect the role of stromal cells in tumor development and cancer therapy. Generating mice in which Cre-ER(T2) is expressed under Flp-FRT-mediated regulation would enable step-wise manipulation of the mouse genome using dual recombinase technology. Such next-generation mouse models would enable sequential mutagenesis to better model cancer and define genes required for tumor maintenance. Here, we generated novel genetically engineered mice that activate or delete Cre-ER(T2) in response to Flp recombinase. To potentially utilize the large number of Cre-loxP-regulated transgenic alleles that have already been targeted into the Rosa26 locus, such as different reporters and mutant genes, we targeted the two novel Cre-ER(T2) alleles into the endogenous Col1a1 locus for ubiquitous expression. In the Col1a1(FRT-Cre-ER-T2-FRT) mice, Flp deletes Cre-ER(T2), so that Cre-ER(T2) is only expressed in cells that have never expressed Flp. In contrast, in the Col1a1(FRT-STOP-FRT-Cre-ER-T2) mice, Flp removes the STOP cassette to allow Cre-ER(T2) expression so that Cre-ER(T2) is only expressed in cells that previously expressed Flp. These two new novel mouse strains will be complementary to each other and will enable the exploration of complex biological questions in development, normal tissue homeostasis and cancer.

A Novel Mouse Line with Epididymal Initial Segment-Specific Expression of Cre Recombinase Driven by the Endogenous Lcn9 Promoter.

Epididymal Initial Segment-Specific Cre Recombinase Activity in Lcn8-Cre Knock-in Mice

Lcn5 promoter directs the region-specific expression of cre recombinase in caput epididymidis of transgenic mice.

Expression Of Tamoxifen-Inducible Cre Recombinase In Lcn5-Creer(T2) Transgenic Mouse Caput Epididymis

Unlocking Genetic Mysteries during the Epic Sperm Journey toward Fertilization: Further Expanding Cre Mouse Lines

Postnatal male germ-cell expression of cre recombinase in Tex101-iCre transgenic mice

Establishment, Characterization, and Application of Pacr-Sp-ntp-egfp Transgenic Mice in Visualizing the Oviduct-Migrating Ability of Sperm from Prss37-null Mice.

Generation and characterization of an inducible renal proximal tubule-specific CreERT2 mouse

Transcriptome profiling of the initial segment and proximal caput of mouse epididymis

Fshb-iCre mice are efficient and specific Cre deleters for the gonadotrope lineage

Deficiency for Lcn8 Causes Epididymal Sperm Maturation Defects in Mice

Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation

Exosc10 deficiency in the initial segment is dispensable for sperm maturation and male fertility in mice

A Transgenic Cre Mouse Line for the Study of Cortical and Hippocampal Development

The generation and characterization of novel Col1a1FRT-Cre-ER-T2-FRT and Col1a1FRT-STOP-FRT-Cre-ER-T2 mice for sequential mutagenesis

Large genomic fragment deletion and functional gene cassette knock-in via Cas9 protein mediated genome editing in one-cell rodent embryos

Expression of Cre Recombinase in an Enhancer-Cre Transgenic Mouse

Generating Endogenous Myh11-driven Cre Mice for Sex-Independent Gene Deletion in Smooth Muscle Cells

Cloning and Primary Characterizations of Rlcn9, a New Member of Epididymal Lipocalins in Rat

Spermatogenic Cell-Specific Gene Mutation in Mice Via CRISPR-Cas9.

CRISPR/Cas9 Promotes Functional Study of Testis Specific X-Linked Gene in Vivo